This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
  • Home
  • /
  • Drugs
  • /
  • V
  • /
  • VENLAFAXINE
  • /
  • Venlafaxine VENLAFAXINE HYDROCHLORIDE 150 mg/1 Zydus Lifesciences Limited
FDA Drug information

Venlafaxine

Read time: 1 mins
Marketing start date: 23 Dec 2024
...
 

Summary of product characteristics


Effective Time

20230928

Version

2

Spl Product Data Elements

Venlafaxine Venlafaxine VENLAFAXINE HYDROCHLORIDE VENLAFAXINE CELLULOSE ACETATE FERROSOFERRIC OXIDE HYPROMELLOSE 2208 (100 MPA.S) MAGNESIUM STEARATE MANNITOL MICROCRYSTALLINE CELLULOSE POLYETHYLENE GLYCOL 400 POVIDONE K90 PROPYLENE GLYCOL SHELLAC SILICON DIOXIDE off-white 1348 Venlafaxine Venlafaxine VENLAFAXINE HYDROCHLORIDE VENLAFAXINE CELLULOSE ACETATE FERROSOFERRIC OXIDE HYPROMELLOSE 2208 (100 MPA.S) MAGNESIUM STEARATE MANNITOL MICROCRYSTALLINE CELLULOSE POLYETHYLENE GLYCOL 400 POVIDONE K90 PROPYLENE GLYCOL SHELLAC SILICON DIOXIDE off-white 1349 Venlafaxine Venlafaxine VENLAFAXINE HYDROCHLORIDE VENLAFAXINE CELLULOSE ACETATE FERROSOFERRIC OXIDE HYPROMELLOSE 2208 (100 MPA.S) MAGNESIUM STEARATE MANNITOL MICROCRYSTALLINE CELLULOSE POLYETHYLENE GLYCOL 400 POVIDONE K90 PROPYLENE GLYCOL SHELLAC SILICON DIOXIDE off-white 1350 Venlafaxine Venlafaxine VENLAFAXINE HYDROCHLORIDE VENLAFAXINE CELLULOSE ACETATE FERROSOFERRIC OXIDE HYPROMELLOSE 2208 (100 MPA.S) MAGNESIUM STEARATE MANNITOL MICROCRYSTALLINE CELLULOSE POLYETHYLENE GLYCOL 400 POVIDONE K90 PROPYLENE GLYCOL SHELLAC SILICON DIOXIDE off-white 1352

Application Number

ANDA215622

Brand Name

Venlafaxine

Generic Name

Venlafaxine

Product Ndc

70771-1651

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Venlafaxine extended-release tablets, 37.5 mg NDC 70771-1649-3 30 Tablets Rx only Venlafaxine extended-release tablets, 75 mg NDC 70771-1650-3 30 Tablets Rx only Venlafaxine extended-release tablets, 150 mg NDC 70771-1651-3 30 Tablets Rx only Venlafaxine extended-release tablets, 225 mg NDC 70771-1652-3 30 Tablets Rx only 37.5 mg label 75 mg label 150 mg label 225 mg label

Spl Medguide

SPL MEDGUIDE

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.